Radiology, Vol 204, 417-423, Copyright © 1997 by Radiological Society of North America

ARTICLES

Paramagnetic metal scavenging by melanin: MR imaging

WS Enochs, P Petherick, A Bogdanova, U Mohr and R Weissleder
Department of Radiology, Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown 02129, USA.

PURPOSE: To quantitate the binding of metals to synthetic melanin in vitro, which is believed to be the reason why melanotic melanomas are hyperintense on T1-weighted magnetic resonance (MR) images, and to test whether such binding by natural melanin can be detected in cultured melanoma cells in vivo with MR imaging. MATERIALS AND METHODS: Seven synthetic metallomelanins were prepared and their metal contents and relaxivities determined. Melanotic PC1A and amelanotic B16 melanoma cells were incubated with increasing concentrations of iron. MR images of synthetic melanin and cell phantoms were obtained. RESULTS: The iron- binding capacities and relaxivities of the different synthetic metallomelanins varied considerably, which reflects the heterogeneous structure of melanin and the complexity of its binding of metals. Nevertheless, the MR signal intensities of the synthetic melanin and cell phantoms show marked increases that scale, respectively, with increasing iron content and iron concentration in the incubation medium. CONCLUSION: Melanotic melanomas are hyperintense on T1-weighted images because of paramagnetic metal scavenging. This observation has implications for the interpretation of MR images, the improved detection of melanomas, and the development of imaging marker genes.

This article has been cited by other articles:

				T. Maeda, U. Tateishi, S. Suzuki, Y. Arai, E. E. Kim, and K. Sugimura Magnetic Resonance Screening Trial for Hepatic Metastasis in Patients with Locally Controlled Choroidal Melanoma Jpn. J. Clin. Oncol., April 1, 2007; 37(4): 282 - 286. [Abstract] [Full Text] [PDF]

				P. Gaviani, M.E. Mullins, T.A. Braga, E.T. Hedley-Whyte, E.F. Halpern, P.S. Schaefer, and J.W. Henson Improved Detection of Metastatic Melanoma by T2*-Weighted Imaging AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 605 - 608. [Abstract] [Full Text] [PDF]

				P. J. Sparrow, J. B. Kurian, T. R. Jones, and M. U. Sivananthan MR Imaging of Cardiac Tumors RadioGraphics, September 1, 2005; 25(5): 1255 - 1276. [Abstract] [Full Text] [PDF]

				S. Albayram, E. Urger, B. Oz, A. Kafadar, C. Islak, and N. Kocer MR Imaging of Pial Melanosis Secondary to a Posterior Fossa Melanotic Ependymoma AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 804 - 808. [Abstract] [Full Text] [PDF]

				Z. J. Wang, G. P. Reddy, M. B. Gotway, B. M. Yeh, S. W. Hetts, and C. B. Higgins CT and MR Imaging of Pericardial Disease RadioGraphics, October 1, 2003; 23(90001): S167 - 180. [Abstract] [Full Text] [PDF]

				H. Alfke, H. Stoppler, F. Nocken, J. T. Heverhagen, B. Kleb, F. Czubayko, and K. J. Klose In Vitro MR Imaging of Regulated Gene Expression Radiology, August 1, 2003; 228(2): 488 - 492. [Abstract] [Full Text] [PDF]

				R. Weissleder and U. Mahmood Molecular Imaging Radiology, May 1, 2001; 219(2): 316 - 333. [Abstract] [Full Text]

				C. Chiles, P. K. Woodard, F. R. Gutierrez, and K. M. Link Metastatic Involvement of the Heart and Pericardium: CT and MR Imaging RadioGraphics, March 1, 2001; 21(2): 439 - 449. [Abstract] [Full Text] [PDF]

				M. Simonova, A. Wall, R. Weissleder, and A. Bogdanov Jr. Tyrosinase Mutants Are Capable of Prodrug Activation in Transfected Nonmelanotic Cells Cancer Res., December 1, 2000; 60(23): 6656 - 6662. [Abstract] [Full Text]

				R. Weissleder Molecular Imaging: Exploring the Next Frontier Radiology, September 1, 1999; 212(3): 609 - 614. [Full Text]

				B. D. Vanzieleghem, M. M. Lemmerling, and R. N. Van Coster Neurocutaneous Melanosis Presenting with Intracranial Amelanotic Melanoma AJNR Am. J. Neuroradiol., March 1, 1999; 20(3): 457 - 460. [Abstract] [Full Text]

				P. R. Stout, D. Dehn, and J. A. Ruth Deposition and Retention of Radiolabeled Serum Constituents in Hair After Systemic Administration Drug Metab. Dispos., September 1, 1998; 26(9): 900 - 906. [Abstract] [Full Text]